Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000821956 | SCV000962732 | benign | CHARGE syndrome | 2024-03-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029088 | SCV004923874 | uncertain significance | Inborn genetic diseases | 2023-10-10 | criteria provided, single submitter | clinical testing | The c.702C>G (p.H234Q) alteration is located in exon 2 (coding exon 1) of the CHD7 gene. This alteration results from a C to G substitution at nucleotide position 702, causing the histidine (H) at amino acid position 234 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005049710 | SCV005675231 | uncertain significance | CHARGE syndrome; Hypogonadotropic hypogonadism 5 with or without anosmia | 2024-05-24 | criteria provided, single submitter | clinical testing |